NASDAQ:SNBR

Withings Omnia Smart Bed Unveiled – Features, Price & How It Compares to Sleep Number and Eight Sleep

Withings unveiled the Omnia, an AI-powered smart mirror that performs 360-degree health scans, at CES 2025. The device measures weight, heart rate, blood pressure, ECG, body composition, and sleep apnea, and features an AI vocal assistant and telemedicine integration. Omnia is not yet for sale, with no announced price or release date. Competing smart beds from Sleep Number and Eight Sleep focus on sleep environment and cost $1,099 to $4,700.

31 August 2025

Comparison·NASDAQ:SNBR·Smart Home

Can Tech Cure Insomnia? Exploring the Gadgets That Promise the Best Sleep of Your Life

The global sleep tech devices market exceeded $21 billion in 2023 and is expanding quickly. In 2024, Samsung and Apple watches received FDA approval for sleep apnea detection, while the Oura Ring Generation 4 added research-grade sensors. Modius Sleep, cleared by the FDA in late 2024, showed 95% sleep improvement in a clinical trial for chronic insomnia. SleepioRx gained FDA clearance in August 2024 as a prescription digital CBT-I therapy.

30 July 2025

KRX:005930·NASDAQ:AAPL·NASDAQ:SNBR·NYSE:PHG·Technology

RTX Shares See 52% Gain in Year - Is It Overvalued at $200?
March 20, 2026, 1:45 AM EDT. RTX's share price rose 51.8% over the past year but dropped 1.4% last month, trading around $200.73. A Discounted Cash Flow (DCF) analysis values RTX at $183.11, suggesting the stock is about 9.6% overvalued based on projected free cash flows. Despite promising aerospace and defense sector positioning, valuation signals are mixed, with a 3 out of 6 score indicating both undervaluation and fair pricing factors. Investors should watch RTX closely for market shifts and updates to fundamentals that could affect its value.